Thalassemia Market Analysis and Pipeline Review, H1 2016: Hexa Reports

Hexa Reports
Market Research Reports and Insightful Company Profiles

Thalassemia Market Size, Symptoms, Treatment, Causes,
Analysis and Pipeline Review, H1 2016

Global Markets Direct's, 'Thalassemia - Pipeline Review, H1 2016', provides an overview of the
Thalassemia pipeline landscape.
The report provides comprehensive information on the therapeutics under development for
Thalassemia, complete with analysis by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological
action of the therapeutics, its complete research and development history and latest news and press
releases. Additionally, the report provides an overview of key players involved in therapeutic
development for Thalassemia and features dormant and discontinued projects.
Browse Detail Report With TOC @
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources.

Hexa Reports
Market Research Reports and Insightful Company Profiles
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to
ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain...